P3 beta-amyloid peptide has a unique and potentially pathogenic immunohistochemical profile in Alzheimer's disease brain
about
Truncated beta-amyloid peptide channels provide an alternative mechanism for Alzheimer's Disease and Down syndromeThe secretases: enzymes with therapeutic potential in Alzheimer disease.Disordered amyloidogenic peptides may insert into the membrane and assemble into common cyclic structural motifs.Cerebrospinal Aβ11-x and 17-x levels as indicators of mild cognitive impairment and patients' stratification in Alzheimer's disease.Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer's disease patients: a biochemical analysisMicroglia in Alzheimer's disease and transgenic models. How close the fit?Monomeric ß-amyloid interacts with type-1 insulin-like growth factor receptors to provide energy supply to neurons.Molecular interactions of Alzheimer amyloid-β oligomers with neutral and negatively charged lipid bilayers.Polymorphism of Alzheimer's Abeta17-42 (p3) oligomers: the importance of the turn location and its conformationA disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse modelBiochemical and structural analysis of the interaction between β-amyloid and fibrinogen.APP/Aβ structural diversity and Alzheimer's disease pathogenesis.Side-chain moieties from the N-terminal region of Aβ are Involved in an oligomer-stabilizing network of interactions
P2860
Q33778899-DF5F03DB-74EC-4438-A959-553AC9B70625Q33887222-F70BBFBB-7E1B-49CF-B11F-638F8E77992CQ34084687-A27D05C4-A0A9-4178-833F-A5BEC3E49338Q34824216-BC7A7299-C06C-40B4-B21B-090B86612D81Q35222076-25ED3A86-1270-4C18-8336-F512E3E82283Q35787094-9042F1F7-41A6-48D8-A3FA-DD8AA6C8A269Q35925948-B3B2BFEE-9EA6-4FED-B1F9-BCD3C403E1AEQ37013734-CB4C8A23-9A2E-407C-A46A-85E0C77A4506Q37303941-D7A58DE8-5C90-422B-B27C-B9E5C9063A6DQ40841974-CCC9F8EF-1D57-4A5C-9706-FF8B59365D3EQ40953485-791ECAB3-6158-421D-B4D6-A6D9C75A9D75Q46320596-BDA7978B-8CFD-4F24-8BBD-7A39809F2F19Q58799799-1FEC1E1C-3357-46E6-B38B-A5D9C4BC146D
P2860
P3 beta-amyloid peptide has a unique and potentially pathogenic immunohistochemical profile in Alzheimer's disease brain
description
1996 nî lūn-bûn
@nan
1996 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
P3 beta-amyloid peptide has a ...... e in Alzheimer's disease brain
@ast
P3 beta-amyloid peptide has a ...... e in Alzheimer's disease brain
@en
P3 beta-amyloid peptide has a ...... e in Alzheimer's disease brain
@nl
type
label
P3 beta-amyloid peptide has a ...... e in Alzheimer's disease brain
@ast
P3 beta-amyloid peptide has a ...... e in Alzheimer's disease brain
@en
P3 beta-amyloid peptide has a ...... e in Alzheimer's disease brain
@nl
prefLabel
P3 beta-amyloid peptide has a ...... e in Alzheimer's disease brain
@ast
P3 beta-amyloid peptide has a ...... e in Alzheimer's disease brain
@en
P3 beta-amyloid peptide has a ...... e in Alzheimer's disease brain
@nl
P2093
P2860
P921
P1476
P3 beta-amyloid peptide has a ...... e in Alzheimer's disease brain
@en
P2093
Catalano R
Higgins LS
Murphy GM Jr
P2860
P304
P407
P577
1996-08-01T00:00:00Z